Pnf Techniques vs Mirror Therapy

May 29, 2026 updated by: Elite College of Management Sciences, Gujranwala, Pakistan

Effectiveness of Pnf Techniques and Mirror Therapy for Lower Limb Mobility in Subacute Stroke Patients

to check the effectiveness of mirror therapy and pnf techniques on lower limb mobility in stroke patients

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab Province
      • Guiranwala, Punjab Province, Pakistan, 52200
        • Elite College of Management Sciences, Gujranwala

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Participants must be stroke patients of age 40-65 years
  • Subacute Stroke
  • Brunnstorm stage 3 or more than 3

Exclusion Criteria:

  • Acute stroke
  • Patient unwilling to participate in study
  • Cardiovascular instability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mirror therapy
Mirror therapy used for cognitive training in stroke patients
Other: Mirror therapy
along with baseline therapeutic exercises treatment, mirror theapy is given to group 1 with 2 sets of 10 repetitions
Experimental: PNF
PNF used for mobility training
Other: PNF
along with baseline therapeutic treatment ,PNF is given to group 2 with 2 sets of 10 repetitions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
fugl-meyer assesment scale
Time Frame: 4 weeks
fugl-meyer assesment scale is used to asses motor recovery and functional in stroke patient . The results calculate on the basis of range 0-10 (severe), 11-20 (moderate), 21-28 (mild).
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Berg Balance Scale
Time Frame: 4 weeks
Berg Balance Scale is used to assess balance and coordination.The result calculate on the basis of ranges 0-20 (severe),21-40 (moderate), 41-56 (severe).
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Elite College of Management Sciences, Gujranwala, Pakistan

Investigators

  • Study Director: Imran Rafiq, PhD Rehabilitation Sciences, Elite College of Management Sciences, Gujranwala

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2025

Primary Completion (Actual)

April 10, 2026

Study Completion (Actual)

April 30, 2026

Study Registration Dates

First Submitted

May 20, 2026

First Submitted That Met QC Criteria

May 29, 2026

First Posted (Actual)

June 3, 2026

Study Record Updates

Last Update Posted (Actual)

June 3, 2026

Last Update Submitted That Met QC Criteria

May 29, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021-066503

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe